Crescent Biopharma CBIO
NASDAQ CBIO
$14.26 -0.33 (-2.26%)
At close: Oct 1, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Return on Assets [ROA] (2014 - 2026)

Updated

Crescent Biopharma's Return on Assets [ROA] was -85.43% in Q2 2026, down 35.06 percentage points from -50.37% a year earlier and down 12.57 percentage points from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Crescent Biopharma came in at -111.59%, down 17.93 percentage points from FY2024.

  • Return on Assets [ROA] has now declined for seven consecutive years, with a five-year change of -78.75 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -93.66% in FY2024 (-17.68 pp), -75.98% in FY2023 (-12.09 pp), -63.89% in FY2022 (-10.40 pp) and -53.48% in FY2021 (-20.65 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q1 2025.
  • Compared with a year earlier, Return on Assets [ROA] was higher in four of the last eight quarters, with an average year-over-year change of +12.33 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q3 2025 (a gain of 160.26 percentage points); the worst was Q3 2024 (a drop of 131.91 percentage points).
  • Per Business Quant data, CBIO's Return on Assets [ROA] in the three quarters before Q2 2026 was -72.86% (Q1 2026), -73.51% (Q4 2025) and -37.84% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Crescent Biopharma 404.96 Mn -302.33 Mn - -85.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -85.43%
Mar 31, 2026 -72.86%
Dec 31, 2025 -73.51%
Sep 30, 2025 -37.84%
Jun 30, 2025 -50.37%
Mar 31, 2025 -141.62%
Dec 31, 2024 -147.54%
Sep 30, 2024 -198.10%
Jun 30, 2024 -133.44%
Mar 31, 2024 -93.75%
Dec 31, 2023 -74.91%
Sep 30, 2023 -66.19%
Jun 30, 2023 -57.19%
Mar 31, 2023 -70.23%
Dec 31, 2022 -86.64%
Sep 30, 2022 -89.03%
Jun 30, 2022 -85.56%
Mar 31, 2022 -72.59%
Dec 31, 2021 -62.71%
Sep 30, 2021 -53.00%
API Access

Crescent Biopharma Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CBIO&period=max&api_key=YOUR_API_KEY